摘要
目的:观察β-受体阻滞剂治疗充血性心力衰竭(CHF)的临床疗效。方法:将94例CHF患者随机分为β-受体阻滞剂组和常规治疗组,β-受体阻滞剂组在常规抗心衰治疗的基础上给予β-受体阻滞剂;常规治疗组采用安慰剂加常规抗心衰治疗。结果:β-受体阻滞剂治疗5年后再住院率和病死率,心功能及超声指标与常规治疗组相比均明显改善。结论:β-受体阻滞剂可显著改善CHF患者的远期预后。
Objective To investigate the therapeutic effect of β - blocker for the patients with congestive heart failure （CHF）. Method 94 patients with CHF were randomly assigned to the β - blocker group （ n = 48） and the routine group （ n = 46）. The β - blocker group was given β - blocker on the basis of anti - failure therapy, and the routine group was given placebo plus anti - failure therapy. Results After 5 years＇treatment with β - blocker, a significant improvement was found in the rate of recurrent hospitalization and mortality, also cardiac function and echocardiography indicators compared with that of the routine group. Conclusion β - blocker can significantly improve the long - term prognosis of patients with CHF.
出处
《吉林医学》
CAS
2007年第1期62-63,共2页
Jilin Medical Journal
